Clinical Trials Browser

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Advanced Endometrial Cancer

Fallopian Tube Neoplasms, Ovarian Neoplasms

Acrocephalosyndactylia, Carcinoma, Transitional Cell, Neoplasm Metastasis

Breast Cancer Metastatic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Adenocarcinoma, Pancreatic Neoplasms

Cholangiocarcinoma

Pancreatic Neoplasms, Lipodystrophy, Congenital Generalized

Urinary Bladder Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Pancreatic Neoplasms

Metastatic Pancreatic Adenocarcinoma

Pancreatic Neoplasms

Carcinoma, Transitional Cell

Bladder Adenocarcinoma

Bile Duct Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Ureteral Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Breast Neoplasms, Breast Neoplasms, Male

Uterine Cervical Neoplasms

Lymphoma, T-Cell

Recurrence, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse

Head and Neck Neoplasms, Neoplasms

Adenocarcinoma of Lung, Lung Neoplasms

Pancreatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Small Cell Lung Carcinoma

Breast Neoplasms, Breast Neoplasms, Male

Bone Neoplasms, Sarcoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Cancer Resectable

Lymphoma, T-Cell, Peripheral

Carcinoma, Non-Small-Cell Lung, Neoplasms

Adenocarcinoma

Pancreatic Neoplasms

Nasopharyngeal Carcinoma, Recurrence

Clinical Trials

BOLSTER

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

GEMCOL

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)

CARMEN-BT01

PRESERVE3

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

EPIC

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma

Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

RELEASE

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study

Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients

ARGO

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor

PGPC1

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer

17-134

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail